Advertisement

Topics

When Will Real World Evidence Be Persuasive? FDA's Temple Offers Perspective

17:07 EDT 29 Jun 2017 | Elsevier Business Intelligence

Postmarketing studies randomized to look at real world data sets could provide the key, Temple suggests; Amgen rep describes ...

Original Article: When Will Real World Evidence Be Persuasive? FDA's Temple Offers Perspective

NEXT ARTICLE

More From BioPortfolio on "When Will Real World Evidence Be Persuasive? FDA's Temple Offers Perspective"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...